Service Hotline
0510-85388603
Query
Search
Lisen's collaborative research work on the development and application of the QCIGISH technology in the early detection of ten cancer types gets published in the Clinical Epigenetics journal.
Lisen's innovative technology was recognized as one of the top six best Asian healthcare startups by Merck in its 2019 Accelerator Program in China.
Tel:
0510-85388603
Fax:
000-12345678